
Thomas Flaten
Stock Analyst at Lake Street
(3.21)
# 2,547
Out of 5,184 analysts
314
Total ratings
44.6%
Success rate
2.1%
Average return
Main Sectors:
Stocks Rated by Thomas Flaten
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IMDX Insight Molecular Diagnostics | Reiterated: Buy | $12 → $9 | $1.97 | +356.85% | 27 | Nov 20, 2026 | |
| AYTU Aytu BioPharma | Downgraded: Hold | $7 → $2.7 | $2.66 | +1.50% | 8 | Nov 17, 2026 | |
| RPID Rapid Micro Biosystems | Downgraded: Hold | $7 → $0.75 | $0.735 | +2.04% | 10 | Nov 16, 2026 | |
| BDSX Biodesix | Reiterated: Buy | $40 → $30 | $7.56 | +296.83% | 16 | Nov 6, 2026 | |
| MDXH MDxHealth | Downgraded: Hold | $5 → $0.5 | $0.1074 | +365.55% | 15 | Oct 16, 2026 | |
| PTHS Pelthos Therapeutics | Reiterated: Buy | $50 → $40 | $6.38 | +526.96% | 8 | Oct 12, 2026 | |
| ATHE Alterity Therapeutics | Reiterated: Buy | $10 | $1.52 | +557.89% | 3 | Oct 5, 2026 | |
| HROW Harrow | Reiterated: Buy | $60 | $30.41 | +97.30% | 21 | Oct 5, 2026 | |
| AEON AEON Biopharma | Reiterated: Buy | $1 → $2 | $0.123 | +1,526.02% | 3 | Oct 1, 2026 | |
| CNTB Connect Biopharma Holdings | Reiterated: Buy | $9 | $0.59 | +1,425.42% | 5 | Oct 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $57 | $32.86 | +73.46% | 26 | Oct 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $2.74 | +228.47% | 2 | Oct 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $20 | $3.28 | +509.76% | 1 | Sep 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $3.46 | +73.41% | 38 | Sep 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $2.25 | +300.00% | 26 | Aug 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $16 | $14.27 | +13.88% | 32 | Aug 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 | $8.25 | +69.70% | 23 | Jun 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $3.30 | +293.94% | 15 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 | $11.85 | +102.53% | 1 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | - | n/a | 15 | May 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1.5 | $0.000001 | n/a | 8 | Nov 29, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $96 → $15 | $0.36 | n/a | 3 | Apr 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3.5 | $1.66 | n/a | 4 | Sep 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 → $50 | $25.13 | n/a | 4 | Mar 1, 2022 |
Insight Molecular Diagnostics
Nov 20, 2026
Reiterated: Buy
Price Target: $12 → $9
Current: $1.97
Upside: +356.85%
Aytu BioPharma
Nov 17, 2026
Downgraded: Hold
Price Target: $7 → $2.7
Current: $2.66
Upside: +1.50%
Rapid Micro Biosystems
Nov 16, 2026
Downgraded: Hold
Price Target: $7 → $0.75
Current: $0.735
Upside: +2.04%
Biodesix
Nov 6, 2026
Reiterated: Buy
Price Target: $40 → $30
Current: $7.56
Upside: +296.83%
MDxHealth
Oct 16, 2026
Downgraded: Hold
Price Target: $5 → $0.5
Current: $0.1074
Upside: +365.55%
Pelthos Therapeutics
Oct 12, 2026
Reiterated: Buy
Price Target: $50 → $40
Current: $6.38
Upside: +526.96%
Alterity Therapeutics
Oct 5, 2026
Reiterated: Buy
Price Target: $10
Current: $1.52
Upside: +557.89%
Harrow
Oct 5, 2026
Reiterated: Buy
Price Target: $60
Current: $30.41
Upside: +97.30%
AEON Biopharma
Oct 1, 2026
Reiterated: Buy
Price Target: $1 → $2
Current: $0.123
Upside: +1,526.02%
Connect Biopharma Holdings
Oct 1, 2026
Reiterated: Buy
Price Target: $9
Current: $0.59
Upside: +1,425.42%
Oct 1, 2026
Reiterated: Buy
Price Target: $57
Current: $32.86
Upside: +73.46%
Oct 1, 2026
Reiterated: Buy
Price Target: $9
Current: $2.74
Upside: +228.47%
Sep 23, 2026
Initiated Coverage: Buy
Price Target: $20
Current: $3.28
Upside: +509.76%
Sep 17, 2026
Reiterated: Buy
Price Target: $6
Current: $3.46
Upside: +73.41%
Aug 21, 2026
Reiterated: Buy
Price Target: $9
Current: $2.25
Upside: +300.00%
Aug 21, 2026
Reiterated: Hold
Price Target: $16
Current: $14.27
Upside: +13.88%
Jun 23, 2026
Reiterated: Buy
Price Target: $14
Current: $8.25
Upside: +69.70%
May 14, 2026
Reiterated: Buy
Price Target: $13
Current: $3.30
Upside: +293.94%
May 8, 2026
Reiterated: Buy
Price Target: $24
Current: $11.85
Upside: +102.53%
May 15, 2025
Reiterated: Hold
Price Target: n/a
Current: -
Upside: n/a
Nov 29, 2023
Reiterated: Buy
Price Target: $1.5
Current: $0.000001
Upside: n/a
Apr 12, 2023
Reiterated: Buy
Price Target: $96 → $15
Current: $0.36
Upside: n/a
Sep 16, 2022
Reiterated: Buy
Price Target: $3.5
Current: $1.66
Upside: n/a
Mar 1, 2022
Reiterated: Buy
Price Target: $60 → $50
Current: $25.13
Upside: n/a